[1] |
曹慧敏,赵冰峰.高通量血液透析及高通量血液透析滤过对骨及矿物质代谢的价值分析[J].中国医药科学,2015,5(12):166-168.
|
[2] |
Martin-Rodriguez S,Caballo C,Gutierrez G,et al.TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia[J].Eur J Clin Invest,2015,45(2):160-169.
|
[3] |
伏广浩,刘晓东.低钙透析液联合高通量血液透析对尿毒症患者钙磷及血管钙化的影响[J].现代医药卫生,2015,31(9):1292-1294.
|
[4] |
邱炽昌.高通量透析对维持性血液透析患者钙、磷代谢影响分析[J].当代医学,2013,19(34):2-4.
|
[5] |
Argyropoulos C,Roumelioti ME,Sattar A,et al.Dialyzer reuse and outcomes of high flux dialysis[J].PLoS One,2015,10(6):e0129575.
|
[6] |
Hoshino J,Yamagata K,Nishi S,et al.Carpal tunnel surgery as proxy for dialysis-related amyloidosis:results from the Japanese society for dialysis therapy[J].Am J Nephrol,2014,39(5):449-458.
|
[7] |
Kim HW,Kim SH,Kim YO,et al.The impact of high-flux dialysis on mortality rates in incidenct and prevalent hemodialysis patients[J].Korean J Intern Med,2014,29(6):774-784.
|
[8] |
康乐,张晓东,刘晓冬,等.高通量血液透析和常规血液透析对尿毒症患者血脂代谢的影响[J].河北医药,2014,36(11):1690-1691.
|
[9] |
罗丹,林彬,张浩,等.高通量血液透析对尿毒症患者血清磷及 iPTH 清除的疗效观察[J].重庆医学,2016,45(22):3137-3139.
|
[11] |
孙小伟,李倩.高通量血液透析联合罗盖全对尿毒症患者钙磷代谢紊乱及微炎症状态的影响[J].海南医学,2016,27(20):3331-3334.
|
[12] |
严功辉.持续性腹膜透析(CAPD)对尿毒症患者钙磷水平的影响[J].现代诊断与治疗,2013,24(7):1494-1495.
|
[13] |
田祥峰.高通量血液透析对老年尿毒症患者60例钙磷代谢异常的临床观察[J].中国中西医结合肾病杂志,2014,15(7):625-626.
|
[10] |
Kim HW,Kim SH,Kim YO,et al.Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function[J].PLoS One,2014,9(6):e97184.
|
[14] |
金炜,陆晓凤,范为荣,等.不同透析方式对尿毒症患者钙磷代谢影响的临床研究[J].中国现代医生,2017,55(13):30-34.
|
[15] |
Reams BD,Dluzniewski PJ,Do TP,et al.Dynamics of cinacalcet use and biochemical control in hemodialysis patients:a retrospective new-user cohort design[J].BMC Nephrology,2015,16(1):175-179.
|